KDR and neoplasm: GOG-218 was the source of several articles identifying several potential predictors for response to anti-angiogenetic therapy: plasmatic concentrations of VEGF and VEGF-R2 [64], tumor VEGF-A expression [65], micro-vessel density (MVD) [66] and IL-6 levels [67].